Caxton Associates (New York)’s Royalty Pharma RPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-42,786	Closed	-$1.69M	–	605
2022 Q4	$1.69M	Buy	+42,786	New	+$1.69M	0.11%	47